Fraunhofer IAF Puts a Diamond Quantum Sensor Inside a Laser Cavity: 100% Optical Contrast and a Calculated Limit Below 400 fT/√Hz, Nature Communications, 22 October 2026
What a Fraunhofer IAF team in Freiburg reported in Nature Communications on 22 October 2026
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
The magnetic field of a thinking brain is hundreds of millions of times weaker than the field of the Earth. Measuring it today usually means a liquid-helium machine or a helmet of vapor-cell sensors, and in both cases a room lined with metal shielding to keep the city's magnetic noise out.
A paper published in Nature Communications on 22 October 2026 describes a different route toward that measurement. A team at the Fraunhofer Institute for Applied Solid State Physics IAF in Freiburg, led on the paper by first author Florian Schall and senior author Jan Jeske, placed a small diamond containing nitrogen-vacancy centers inside the cavity of a semiconductor laser. The atomic defects in the diamond respond to magnetic fields, and in this arrangement they decide whether the laser runs at all. The authors report that the magnetic resonance of the diamond can switch the laser completely off, which gives the sensor a full on-off signal where conventional diamond sensors see a change of a few percent in their glow.
The technique is called laser threshold magnetometry. It was first proposed in theory, and the Freiburg group now shows it working on a laboratory bench with real diamonds. The paper, Laser-enhanced quantum sensing boosts sensitivity and dynamic range, was received on 18 August 2026 and accepted on 22 September 2026.
The authors connect the result directly to medicine. They write that the improved performance could enable a new generation of quantum sensors for medical applications and could help measure physiological and neurological signals, and they name magnetoencephalography outside magnetically shielded rooms as one application in view. Magnetoencephalography, or MEG, maps brain activity from the magnetic fields that neurons produce, and hospitals use it today to locate the source of seizures before epilepsy surgery.
The paper is careful about what it has and has not shown. Its headline sensitivity is a calculated limit for the setup, and the authors state plainly that it has not yet been reached in an actual measurement. That distinction shapes everything a clinician or a hospital buyer should take from it.
Forescout's October 2026 Healthcare Report Finds 6% of Medical IoT Devices on Post-Quantum-Capable SSH and 31% of Exposed Hospital Systems on TLS 1.3
What a hospital-network survey of 2.5 million devices found, October 2026
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
A CT scan taken in a hospital this week will still describe the same patient in 2040. The encryption that carries that image from the scanner to the archive, and from the archive to an outside radiologist, was mostly designed for a world without large quantum computers.
The security firm Forescout has now put numbers on that gap. Its research report PQC in Healthcare: From Data Risk to Migration Readiness, released in early October 2026, looks at how far hospital networks have moved toward post-quantum cryptography, the new public-key algorithms meant to resist a future quantum computer. The answer is uneven. In the enterprise networks Forescout tracks, half of ordinary IT devices run OpenSSH versions that support the new algorithms. Among the devices of the Internet of Medical Things, such as infusion pumps, patient monitors and imaging equipment, the share is 6%.
The report also searched the open internet for hospital systems that anyone can reach. It found more than 5,500 of them, mostly electronic medical record platforms and image archives, and only 31% of those systems support TLS 1.3, the only version of the web's standard encryption protocol that can carry the standardized post-quantum key exchange.
For a hospital board or a chief medical information officer, the figures separate the devices a hospital can upgrade on its own from the devices whose encryption changes only when a manufacturer ships new firmware. They come from one vendor's customer data and from public internet scans, so they describe the networks Forescout can see, not a random sample of all hospitals.
The dataset comes from Forescout's own device cloud: more than 2.5 million connected devices across more than 50 healthcare delivery organizations, an average of around 50,000 devices per organization. About two-thirds are IT assets, such as workstations and servers. The rest are network equipment, building and facility systems, and medical devices, which make up about 5% of the total.
Siloton Announces £8.4 Million Innovate UK Contract on 14 October 2026 to Trial Its Chip-Based Handheld OCT Eye Scanner With Sunderland Eye Hospital
Siloton takes its chip-based retinal scanner toward NHS trials
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
The Bristol start-up Siloton has won an £8.4 million contract from Innovate UK to finish two versions of its handheld eye scanner, one for clinics and one for patients' homes, and to test both over the next two years. The company announced the award on 14 October 2026. The money comes through Contracts for Innovation: Quantum Missions Primer, a UK Research and Innovation program in which public bodies set a problem and pay companies to develop a solution.
The device performs optical coherence tomography, or OCT, the scan that eye clinics use to see the layers of the retina in cross-section. Siloton says it has compressed a tabletop's worth of fragile optics onto a photonic chip smaller than a £1 coin, set in a binocular-style headset that a patient looks into. Clinical trials of the in-clinic version will run with Sunderland Specialist Eye Hospital, and York Health Economics Consortium will use the trial data to refine estimates of what the system could save the NHS.
For a hospital eye service, the question is practical. OCT is the main tool for following age-related macular degeneration, diabetic eye disease and glaucoma, and most patients on those pathways need repeat scans for years. A scanner small and cheap enough to sit in a community clinic, or in a living room, would change where those repeat visits happen.
According to Siloton's press release of 14 October 2026, the contract pays for the design of in-clinic and at-home versions of its GiraffeOCT device and for trials on both. Patients in the North East and North Cumbria will have access to the in-clinic system during the Sunderland trials. The company expects the funding to shorten its development by up to two years, and it plans to grow its staff to 16 by August 2028, with hiring in photonics, electronics and software.
Chief executive Alasdair Price said the contract also covers a wider range of detectable diseases, integration of a second-generation chip called BlueJay, which he described as the same architecture used in the company's system for astronauts, and a cloud platform behind the service. The European Space Agency is listed as a customer; it wants a way to follow the eye problems astronauts often develop in orbit. Siloton also plans a second-generation device, CheetahOCT, designed to measure further layers of the retina, and intends to raise more investment on the back of the award.
The company frames the need with NHS figures: ophthalmology is the busiest outpatient specialty in England, with about nine million attendances in 2023/24, and at the end of July 2026 nearly 623,000 people were waiting for an eye appointment, 8.7 percent of all NHS waits. These numbers come from the press release, which does not cite the underlying NHS dataset.
SEALSQ's 9 September 2026 Interview on Fifteen-to-Twenty-Year Medical Device Lives, and the QS7001 Page That Still Lists Kyber and Dilithium 2
Quentir Medicine Monitor
Evidence-based insights for quantum medicine.
On 9 September 2026 Carlos Moreira, founder and chief executive of the Nasdaq-listed semiconductor company SEALSQ, described in a published interview a post-quantum exposure specific to connected physical systems, among them medical devices, which he sets alongside the familiar risk of stored data waiting to be decrypted later. His reason rests on an arithmetic any hospital finance office already runs: equipment bought today could remain in service well beyond the transition date NIST has proposed.
Many connected devices stay fifteen or twenty years in service and cannot be swapped out quickly. A draft NIST report proposes that the public-key algorithms those devices ship with become disallowed after 2035, with the weaker parameter sizes deprecated five years earlier. The company's answer is a secure microcontroller called the QS7001, whose product page names medical and healthcare devices as a target market, and whose specification sheet still lists Kyber and Dilithium 2, the names those algorithms carried before NIST standardized them.
A 90-Degree Antenna for a Difficult Organ
The eye makes 7-tesla MRI work hard
The human eye is small, moves easily, and sits among tissues that respond differently to a strong radiofrequency field. Higher magnetic fields can reveal finer anatomy, but they can also create shading, signal voids, and local heating. A team in Berlin and Rostock built a metamaterial antenna around that problem. The printed circuit board bends through 90 degrees over the eyes. Forty subwavelength copper cells are integrated with a two-channel transmit-and-receive loop to reshape the field at the operating frequency of a 7-tesla scanner.
The prototype reached human imaging
The antenna was tested in phantoms, five healthy adults, and one person with treated retinal disease. Three healthy volunteers received direct comparisons with a matched conventional loop. The new design increased transmit efficiency and received signal across the reported eye measurements. A flat version also extended coverage across the occipital region in two healthy volunteers. Safety work combined electromagnetic simulation, human voxel models, magnetic-resonance thermometry, and fiber-optic temperature probes. These results make the device a serious ocular MRI prototype, while the small cohort and technical endpoints stop well short of diagnostic superiority or routine care.
The quantum boundary matters
MRI reads signals produced by nuclear spin and magnetic resonance, placing this work in the quantum-sensing pillar. The metamaterial itself is an engineered radiofrequency structure rather than a quantum computer or algorithm. A contemporary UC San Diego account describes a separate line of quantum metamaterials built from nanoscale quantum elements and notes the broader use of metamaterials to shape MRI fields. The two research lines meet at materials control, but they should not be treated as the same mechanism. For hospitals, the relevant questions remain attached to the actual device: field uniformity, heating, scan performance, reproducibility, patient comfort, qualification, and whether better signal changes a clinical decision.
The Quiet Defect Inside a Noisy Diamond
A diamond defect can have a cleaner optical voice
At room temperature, vibrations in a diamond lattice usually disturb the light emitted by an atom-sized defect. A research team led from the University of Illinois has reported a newly identified IL1 color center in nanodiamonds that behaves differently. The peer-reviewed paper describes single-photon emission with linewidths down to 0.3 nanometers at room temperature and brightness above 10 million counts per second at saturation. The usual broad phonon sideband was almost entirely suppressed. Instead, the emitter coupled mainly to one localized vibrational mode outside the diamond phonon band.
The result changes one engineering constraint
That combination matters because many solid-state quantum emitters pay a heavy thermal price for optical coherence. The IL1 result shows room-temperature emission from a real material under laboratory measurement. It does not yet show a complete sensor. The paper reports no controlled spin state, stable charge protocol, integrated readout package, biological sample, analyte, patient cohort, or clinical task. The authors themselves identify spin and charge control, quantum memory, and engineered versions of the defect as future questions.
Medicine enters through the temperature budget
Medical sensing often has to meet living tissue, routine laboratory workflows, or compact instruments at ordinary temperatures. A quantum component that preserves a narrow optical signal without deep cooling could eventually reduce one obstacle between materials physics and a usable device. Sensitivity, selectivity, calibration, biocompatibility, fabrication yield, and reproducibility remain separate problems.
Quentir reads IL1 as an experimental materials result with a credible sensing path and a still-open medical case. Its value today is precise: the team found an unusual way for an emitter to remain optically clean while the surrounding crystal vibrates. The next useful milestones are an integrated sensor, a defined target, comparison with existing diamond defects, and testing in the kind of sample the intended medical job actually involves.
A Surgical Simulator Enters the Real-Time Loop
The loop is now fast enough for interaction
NVIDIA's Cosmos-H-Dreams takes an initial surgical video frame and a live stream of robotic actions, then generates the next scene in 12-frame blocks. The developers report roughly 160 frames per second on one RTX PRO 6000 GPU, up from about 10 frames per second for standard Cosmos-H-Surgical-Simulator inference. That throughput moves the system into real-time surgical simulation: a keyboard, Meta Quest controller, or learned robotic policy can act against the scene while the model keeps generating. The release specializes in tabletop suturing with the da Vinci Research Kit. It uses a 44-dimensional action format, causal attention, a streaming key-value cache, and a student model distilled from a bidirectional surgical-video teacher. This changes the experiment from a completed clip inspected later into a responsive environment that can be interrupted while a rollout is still unfolding.
Fidelity now becomes the demanding test
Interactivity supports closed-loop evaluation, but speed alone cannot show that the simulated robot behaves like the physical robot. The training material includes successful demonstrations along with needle drops, missed throws, unsuccessful knots, and out-of-distribution episodes. That is valuable because a simulator used for policy development must reproduce the consequences of poor actions as well as clean demonstrations. The developers themselves call for benchmarks covering tool-tip reach, pose accuracy, gripper cycles, idle stability, counterfactual actions, long-horizon drift, and agreement between simulated and physical policy outcomes.
The current release is a research and development platform for rehearsal, interactive demonstration, synthetic data, and robotic-policy testing. It does not report clinical performance, diagnostic value, prospective procedure studies, or validated transfer to patient care. Quentir reads it as an infrastructure advance whose medical value will depend on a precise simulation contract: the starting scene, action stream, generated response, time horizon, and physical comparator. The loop is fast enough to challenge in real time. Its fidelity remains open to independent testing.